LVCLF.US Living Cell Technologies Limited

Healthcare Biotechnology USA Stocks
0.0072 USD
Close of Nov 15, 2026
0.0035 0.0095
Market cap
USD 14.5M
P/E
-
P/B
4.98x
ROE
-66.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is LVCLF.US undervalued?

Graham number

The Graham number of Living Cell Technologies Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Living Cell Technologies Limited fundamental analysis

No fundamental analysis for Living Cell Technologies Limited yet.

Living Cell Technologies Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Living Cell Technologies Limited

Algorae Pharmaceuticals Limited, an AI-enabled pharmaceutical development company, engages in the research and development of living cells technologies primarily in Australia and New Zealand. The company's product pipeline includes AI-116, a novel combination drug candidate made up of donepezil and cannabidiol for the treatment of dementia, including Alzheimer's disease; AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingr…

Full company profile